Polycystin-1作为外周动脉疾病新型生物标志物的初步前瞻性研究
该前瞻性研究纳入70例颈动脉内膜切除术患者,检测血清PC-1水平并分析其与斑块特征及p53/p38/p21信号通路的关系。PC-1阳性样本中p21和磷酸化p38表达增加但未达统计学显著性。
要点
- PC-1水平与年龄、BMI、血脂、HbA1c及颈动脉狭窄程度显著相关(P<0.0001)。
- PC-1阳性样本中p53/p38/p21通路激活增加,但差异无统计学意义。
核心结论
- PC-1可能作为颈动脉粥样硬化的潜在生物标志物,与疾病进展及机械转导信号相关。
- 需更大规模队列研究验证上述观察并探索PC-1作为血管疾病治疗靶点的作用。
研究设计与样本
- 前瞻性纳入70例接受颈动脉内膜切除术的患者。
- 采用ELISA检测血清PC-1水平,Western blot评估p53/p38/p21信号通路活化。
- 患者分为症状组(n=17)和无症状组(n=53)。
主要发现
- PC-1水平与年龄、BMI、血脂、HbA1c及颈动脉狭窄严重程度显著相关(P<0.0001)。
- PC-1水平与血清肌酐无显著相关性。
- PC-1阳性样本中p21和磷酸化p38表达增加,但差异未达统计学显著性。
- 热图分析显示PC-1阳性样本中p53/p38/p21激活更明显,尤其在男性患者中。
关键数值与推荐
- PC-1与年龄、BMI、血脂、HbA1c、颈动脉狭窄严重程度的相关性P值均<0.0001。
- PC-1阳性样本中p21和磷酸化p38表达增加但无统计学显著性。
临床怎么用
- PC-1可能作为颈动脉粥样硬化评估的候选血清标志物,但当前证据尚不足以指导临床决策。
- PC-1与代谢指标及狭窄程度的相关性提示其或可用于风险分层,需进一步验证。
局限性
- 本研究为初步前瞻性研究,样本量较小(共70例)。
- PC-1阳性样本中信号通路差异未达统计学显著性。
- 需更大规模队列验证PC-1作为生物标志物的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atherosclerosis remains a leading cause of morbidity and mortality worldwide. Recent studies highlight the potential role of mechanosensitive molecules, particularly Polycystin-1 (PC-1), in vascular pathology. However, its significance in carotid atherosclerosis remains largely unexplored. This study aims to evaluate PC-1 serum levels and its association with atherosclerotic plaque characteristics and the p53/p38/p21 signaling pathway. METHODS: A total of 70 patients undergoing carotid endarterectomy were prospectively enrolled in this study. PC-1 levels in serum were measured using enzyme-linked immunosorbent assay, while Western blot analysis was performed to assess p53/p38/p21 signaling pathway activation. Patients were stratified into symptomatic (n = 17) and asymptomatic (n = 53) groups. Correlations between PC-1 levels, clinical parameters, plaque characteristics, and protein expression were analyzed using Student's t-test and chi-square tests. RESULTS: PC-1 was detected in ten patients (7 asymptomatic, 3 symptomatic), with levels significantly correlating with age (P < 0.0001), body mass index (P < 0.0001), lipid profile (P < 0.0001), hemoglobin A1c (P < 0.0001), and carotid stenosis severity (P < 0.0001). No significant correlation was found between PC-1 levels and serum creatinine. Western blot analysis revealed an increase in p21 and phospho-p38 expression in PC-1-positive samples, although this difference did not reach statistical significance. Heatmap analysis showed greater p53/p38/p21 activation in PC-1-positive samples, particularly in male patients. CONCLUSION: These findings suggest that PC-1 may serve as a potential biomarker for carotid atherosclerosis, with implications for disease progression and mechanotransduction signaling. Further studies with larger cohorts are needed to validate these observations and explore the role of PC-1 as a therapeutic target in vascular disease.
引用
- Theodoridis PG, Georgopoulos S, Bakoyiannis C, et al. Polycystin-1 as a Novel Biomarker for Peripheral Artery Disease: Findings from a Pilot Prospective Study. Ann Vasc Surg. 2025. PMID: 40706843. doi:10.1016/j.avsg.2025.07.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。